Obsidian Therapeutics, Inc. Common Stock (OBX) is a publicly traded the market company. As of September 20, 2026, OBX trades at $17.68 with a market cap of $1.10B and a P/E ratio of 0.00. OBX moved +1.14% today. Year to date, OBX is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $14.57 to $49.97. Analyst consensus is strong buy with an average price target of $42.67. Rallies surfaces OBX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover OBX: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $42.67.
| Metric | Value |
|---|---|
| Price | $17.68 |
| Market Cap | $1.10B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $49.97 |
| 52-Week Low | $14.57 |
| Volume | 469.64K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
4 analysts cover OBX: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $42.67.